nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—Busulfan—hematologic cancer	0.471	0.871	CbGbCtD
Ethacrynic acid—ALB—hematologic cancer	0.157	1	CbGaD
Ethacrynic acid—ALB—Imatinib—hematologic cancer	0.0233	0.043	CbGbCtD
Ethacrynic acid—ALB—Prednisone—hematologic cancer	0.0153	0.0283	CbGbCtD
Ethacrynic acid—ALB—Irinotecan—hematologic cancer	0.0146	0.0269	CbGbCtD
Ethacrynic acid—SLC22A6—Methotrexate—hematologic cancer	0.00904	0.0167	CbGbCtD
Ethacrynic acid—ALB—Methotrexate—hematologic cancer	0.0077	0.0142	CbGbCtD
Ethacrynic acid—GSTA2—hematopoietic system—hematologic cancer	0.00275	0.117	CbGeAlD
Ethacrynic acid—SLC12A1—hematopoietic system—hematologic cancer	0.0025	0.107	CbGeAlD
Ethacrynic acid—GSTA2—gonad—hematologic cancer	0.00209	0.0893	CbGeAlD
Ethacrynic acid—GSTA2—blood—hematologic cancer	0.00182	0.0778	CbGeAlD
Ethacrynic acid—SLC12A1—blood—hematologic cancer	0.00165	0.0708	CbGeAlD
Ethacrynic acid—GSTA2—lung—hematologic cancer	0.00159	0.0682	CbGeAlD
Ethacrynic acid—GSTA2—testis—hematologic cancer	0.0015	0.0644	CbGeAlD
Ethacrynic acid—ATP1A1—hematopoietic system—hematologic cancer	0.00145	0.0622	CbGeAlD
Ethacrynic acid—SLC12A1—testis—hematologic cancer	0.00137	0.0586	CbGeAlD
Ethacrynic acid—ATP1A1—gonad—hematologic cancer	0.00111	0.0473	CbGeAlD
Ethacrynic acid—ATP1A1—blood—hematologic cancer	0.000963	0.0412	CbGeAlD
Ethacrynic acid—ATP1A1—bone marrow—hematologic cancer	0.000932	0.0399	CbGeAlD
Ethacrynic acid—ATP1A1—lung—hematologic cancer	0.000844	0.0361	CbGeAlD
Ethacrynic acid—ALB—testis—hematologic cancer	0.000827	0.0354	CbGeAlD
Ethacrynic acid—ATP1A1—testis—hematologic cancer	0.000797	0.0341	CbGeAlD
Ethacrynic acid—ALB—lymph node—hematologic cancer	0.0006	0.0257	CbGeAlD
Ethacrynic acid—ATP1A1—lymph node—hematologic cancer	0.000577	0.0247	CbGeAlD
Ethacrynic acid—Ill-defined disorder—Dexamethasone—hematologic cancer	8.78e-05	0.000424	CcSEcCtD
Ethacrynic acid—Headache—Bortezomib—hematologic cancer	8.77e-05	0.000423	CcSEcCtD
Ethacrynic acid—Discomfort—Triamcinolone—hematologic cancer	8.77e-05	0.000423	CcSEcCtD
Ethacrynic acid—Rash—Bleomycin—hematologic cancer	8.76e-05	0.000423	CcSEcCtD
Ethacrynic acid—Pain—Cisplatin—hematologic cancer	8.76e-05	0.000423	CcSEcCtD
Ethacrynic acid—Dermatitis—Bleomycin—hematologic cancer	8.76e-05	0.000423	CcSEcCtD
Ethacrynic acid—Asthenia—Carmustine—hematologic cancer	8.7e-05	0.00042	CcSEcCtD
Ethacrynic acid—Vomiting—Vinorelbine—hematologic cancer	8.7e-05	0.00042	CcSEcCtD
Ethacrynic acid—Body temperature increased—Gemcitabine—hematologic cancer	8.68e-05	0.000419	CcSEcCtD
Ethacrynic acid—Neutropenia—Epirubicin—hematologic cancer	8.65e-05	0.000417	CcSEcCtD
Ethacrynic acid—Diarrhoea—Thalidomide—hematologic cancer	8.64e-05	0.000417	CcSEcCtD
Ethacrynic acid—Asthenia—Alitretinoin—hematologic cancer	8.62e-05	0.000416	CcSEcCtD
Ethacrynic acid—Rash—Vinorelbine—hematologic cancer	8.62e-05	0.000416	CcSEcCtD
Ethacrynic acid—Dermatitis—Vinorelbine—hematologic cancer	8.61e-05	0.000416	CcSEcCtD
Ethacrynic acid—Headache—Vinorelbine—hematologic cancer	8.57e-05	0.000413	CcSEcCtD
Ethacrynic acid—Dysphagia—Doxorubicin—hematologic cancer	8.56e-05	0.000413	CcSEcCtD
Ethacrynic acid—Malaise—Betamethasone—hematologic cancer	8.53e-05	0.000412	CcSEcCtD
Ethacrynic acid—Malaise—Dexamethasone—hematologic cancer	8.53e-05	0.000412	CcSEcCtD
Ethacrynic acid—Asthenia—Ifosfamide—hematologic cancer	8.52e-05	0.000411	CcSEcCtD
Ethacrynic acid—Vertigo—Dexamethasone—hematologic cancer	8.5e-05	0.00041	CcSEcCtD
Ethacrynic acid—Vertigo—Betamethasone—hematologic cancer	8.5e-05	0.00041	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Cisplatin—hematologic cancer	8.44e-05	0.000407	CcSEcCtD
Ethacrynic acid—Haematuria—Methotrexate—hematologic cancer	8.4e-05	0.000405	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Epirubicin—hematologic cancer	8.34e-05	0.000403	CcSEcCtD
Ethacrynic acid—Nausea—Bortezomib—hematologic cancer	8.32e-05	0.000402	CcSEcCtD
Ethacrynic acid—Asthenia—Vincristine—hematologic cancer	8.31e-05	0.000401	CcSEcCtD
Ethacrynic acid—Vomiting—Thiotepa—hematologic cancer	8.3e-05	0.000401	CcSEcCtD
Ethacrynic acid—Diarrhoea—Carmustine—hematologic cancer	8.3e-05	0.000401	CcSEcCtD
Ethacrynic acid—Nausea—Bleomycin—hematologic cancer	8.26e-05	0.000398	CcSEcCtD
Ethacrynic acid—Rash—Thiotepa—hematologic cancer	8.23e-05	0.000397	CcSEcCtD
Ethacrynic acid—Dermatitis—Thiotepa—hematologic cancer	8.23e-05	0.000397	CcSEcCtD
Ethacrynic acid—Diarrhoea—Alitretinoin—hematologic cancer	8.22e-05	0.000397	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Methotrexate—hematologic cancer	8.22e-05	0.000397	CcSEcCtD
Ethacrynic acid—Convulsion—Betamethasone—hematologic cancer	8.2e-05	0.000396	CcSEcCtD
Ethacrynic acid—Convulsion—Dexamethasone—hematologic cancer	8.2e-05	0.000396	CcSEcCtD
Ethacrynic acid—Headache—Thiotepa—hematologic cancer	8.18e-05	0.000395	CcSEcCtD
Ethacrynic acid—Decreased appetite—Etoposide—hematologic cancer	8.16e-05	0.000394	CcSEcCtD
Ethacrynic acid—Diarrhoea—Ifosfamide—hematologic cancer	8.13e-05	0.000392	CcSEcCtD
Ethacrynic acid—Nausea—Vinorelbine—hematologic cancer	8.12e-05	0.000392	CcSEcCtD
Ethacrynic acid—Body temperature increased—Cisplatin—hematologic cancer	8.1e-05	0.000391	CcSEcCtD
Ethacrynic acid—Asthenia—Irinotecan—hematologic cancer	8.09e-05	0.000391	CcSEcCtD
Ethacrynic acid—Asthenia—Mitoxantrone—hematologic cancer	8.09e-05	0.000391	CcSEcCtD
Ethacrynic acid—Fatigue—Etoposide—hematologic cancer	8.09e-05	0.00039	CcSEcCtD
Ethacrynic acid—Jaundice—Epirubicin—hematologic cancer	8.04e-05	0.000388	CcSEcCtD
Ethacrynic acid—Vomiting—Thalidomide—hematologic cancer	8.03e-05	0.000388	CcSEcCtD
Ethacrynic acid—Anxiety—Dexamethasone—hematologic cancer	8.03e-05	0.000387	CcSEcCtD
Ethacrynic acid—Anxiety—Betamethasone—hematologic cancer	8.03e-05	0.000387	CcSEcCtD
Ethacrynic acid—Pain—Etoposide—hematologic cancer	8.02e-05	0.000387	CcSEcCtD
Ethacrynic acid—Neutropenia—Doxorubicin—hematologic cancer	8e-05	0.000386	CcSEcCtD
Ethacrynic acid—Rash—Thalidomide—hematologic cancer	7.96e-05	0.000384	CcSEcCtD
Ethacrynic acid—Discomfort—Betamethasone—hematologic cancer	7.96e-05	0.000384	CcSEcCtD
Ethacrynic acid—Discomfort—Dexamethasone—hematologic cancer	7.96e-05	0.000384	CcSEcCtD
Ethacrynic acid—Dermatitis—Thalidomide—hematologic cancer	7.96e-05	0.000384	CcSEcCtD
Ethacrynic acid—Diarrhoea—Vincristine—hematologic cancer	7.92e-05	0.000382	CcSEcCtD
Ethacrynic acid—Headache—Thalidomide—hematologic cancer	7.91e-05	0.000382	CcSEcCtD
Ethacrynic acid—Pain—Prednisolone—hematologic cancer	7.91e-05	0.000382	CcSEcCtD
Ethacrynic acid—Asthenia—Gemcitabine—hematologic cancer	7.88e-05	0.00038	CcSEcCtD
Ethacrynic acid—Haematuria—Epirubicin—hematologic cancer	7.86e-05	0.000379	CcSEcCtD
Ethacrynic acid—Vision blurred—Prednisone—hematologic cancer	7.76e-05	0.000375	CcSEcCtD
Ethacrynic acid—Nausea—Thiotepa—hematologic cancer	7.76e-05	0.000374	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Etoposide—hematologic cancer	7.73e-05	0.000373	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Doxorubicin—hematologic cancer	7.72e-05	0.000373	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mitoxantrone—hematologic cancer	7.72e-05	0.000372	CcSEcCtD
Ethacrynic acid—Diarrhoea—Irinotecan—hematologic cancer	7.72e-05	0.000372	CcSEcCtD
Ethacrynic acid—Vomiting—Carmustine—hematologic cancer	7.71e-05	0.000372	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Epirubicin—hematologic cancer	7.69e-05	0.000371	CcSEcCtD
Ethacrynic acid—Rash—Carmustine—hematologic cancer	7.65e-05	0.000369	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Prednisone—hematologic cancer	7.64e-05	0.000369	CcSEcCtD
Ethacrynic acid—Dermatitis—Carmustine—hematologic cancer	7.64e-05	0.000369	CcSEcCtD
Ethacrynic acid—Vomiting—Alitretinoin—hematologic cancer	7.64e-05	0.000369	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Prednisolone—hematologic cancer	7.63e-05	0.000368	CcSEcCtD
Ethacrynic acid—Headache—Carmustine—hematologic cancer	7.6e-05	0.000367	CcSEcCtD
Ethacrynic acid—Rash—Alitretinoin—hematologic cancer	7.58e-05	0.000366	CcSEcCtD
Ethacrynic acid—Dermatitis—Alitretinoin—hematologic cancer	7.57e-05	0.000365	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Dexamethasone—hematologic cancer	7.56e-05	0.000365	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Betamethasone—hematologic cancer	7.56e-05	0.000365	CcSEcCtD
Ethacrynic acid—Vomiting—Ifosfamide—hematologic cancer	7.55e-05	0.000364	CcSEcCtD
Ethacrynic acid—Headache—Alitretinoin—hematologic cancer	7.53e-05	0.000363	CcSEcCtD
Ethacrynic acid—Diarrhoea—Gemcitabine—hematologic cancer	7.52e-05	0.000363	CcSEcCtD
Ethacrynic acid—Nausea—Thalidomide—hematologic cancer	7.5e-05	0.000362	CcSEcCtD
Ethacrynic acid—Rash—Ifosfamide—hematologic cancer	7.49e-05	0.000361	CcSEcCtD
Ethacrynic acid—Dermatitis—Ifosfamide—hematologic cancer	7.48e-05	0.000361	CcSEcCtD
Ethacrynic acid—Jaundice—Doxorubicin—hematologic cancer	7.44e-05	0.000359	CcSEcCtD
Ethacrynic acid—Malaise—Prednisone—hematologic cancer	7.43e-05	0.000359	CcSEcCtD
Ethacrynic acid—Body temperature increased—Etoposide—hematologic cancer	7.42e-05	0.000358	CcSEcCtD
Ethacrynic acid—Vertigo—Prednisone—hematologic cancer	7.4e-05	0.000357	CcSEcCtD
Ethacrynic acid—Tinnitus—Methotrexate—hematologic cancer	7.37e-05	0.000356	CcSEcCtD
Ethacrynic acid—Vomiting—Vincristine—hematologic cancer	7.36e-05	0.000355	CcSEcCtD
Ethacrynic acid—Anorexia—Betamethasone—hematologic cancer	7.36e-05	0.000355	CcSEcCtD
Ethacrynic acid—Anorexia—Dexamethasone—hematologic cancer	7.36e-05	0.000355	CcSEcCtD
Ethacrynic acid—Asthenia—Cisplatin—hematologic cancer	7.35e-05	0.000355	CcSEcCtD
Ethacrynic acid—Fatigue—Triamcinolone—hematologic cancer	7.34e-05	0.000354	CcSEcCtD
Ethacrynic acid—Rash—Vincristine—hematologic cancer	7.3e-05	0.000352	CcSEcCtD
Ethacrynic acid—Dermatitis—Vincristine—hematologic cancer	7.3e-05	0.000352	CcSEcCtD
Ethacrynic acid—Pain—Triamcinolone—hematologic cancer	7.28e-05	0.000351	CcSEcCtD
Ethacrynic acid—Haematuria—Doxorubicin—hematologic cancer	7.27e-05	0.000351	CcSEcCtD
Ethacrynic acid—Headache—Vincristine—hematologic cancer	7.26e-05	0.00035	CcSEcCtD
Ethacrynic acid—Nausea—Carmustine—hematologic cancer	7.21e-05	0.000348	CcSEcCtD
Ethacrynic acid—Vomiting—Irinotecan—hematologic cancer	7.17e-05	0.000346	CcSEcCtD
Ethacrynic acid—Vomiting—Mitoxantrone—hematologic cancer	7.17e-05	0.000346	CcSEcCtD
Ethacrynic acid—Nausea—Alitretinoin—hematologic cancer	7.14e-05	0.000345	CcSEcCtD
Ethacrynic acid—Convulsion—Prednisone—hematologic cancer	7.14e-05	0.000345	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Doxorubicin—hematologic cancer	7.12e-05	0.000344	CcSEcCtD
Ethacrynic acid—Rash—Mitoxantrone—hematologic cancer	7.11e-05	0.000343	CcSEcCtD
Ethacrynic acid—Rash—Irinotecan—hematologic cancer	7.11e-05	0.000343	CcSEcCtD
Ethacrynic acid—Dermatitis—Irinotecan—hematologic cancer	7.1e-05	0.000343	CcSEcCtD
Ethacrynic acid—Dermatitis—Mitoxantrone—hematologic cancer	7.1e-05	0.000343	CcSEcCtD
Ethacrynic acid—Chills—Methotrexate—hematologic cancer	7.1e-05	0.000343	CcSEcCtD
Ethacrynic acid—Headache—Mitoxantrone—hematologic cancer	7.07e-05	0.000341	CcSEcCtD
Ethacrynic acid—Headache—Irinotecan—hematologic cancer	7.07e-05	0.000341	CcSEcCtD
Ethacrynic acid—Nausea—Ifosfamide—hematologic cancer	7.06e-05	0.000341	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Triamcinolone—hematologic cancer	7.01e-05	0.000338	CcSEcCtD
Ethacrynic acid—Diarrhoea—Cisplatin—hematologic cancer	7.01e-05	0.000338	CcSEcCtD
Ethacrynic acid—Anxiety—Prednisone—hematologic cancer	6.99e-05	0.000337	CcSEcCtD
Ethacrynic acid—Vomiting—Gemcitabine—hematologic cancer	6.99e-05	0.000337	CcSEcCtD
Ethacrynic acid—Discomfort—Prednisone—hematologic cancer	6.93e-05	0.000334	CcSEcCtD
Ethacrynic acid—Rash—Gemcitabine—hematologic cancer	6.93e-05	0.000334	CcSEcCtD
Ethacrynic acid—Dermatitis—Gemcitabine—hematologic cancer	6.92e-05	0.000334	CcSEcCtD
Ethacrynic acid—Tinnitus—Epirubicin—hematologic cancer	6.9e-05	0.000333	CcSEcCtD
Ethacrynic acid—Headache—Gemcitabine—hematologic cancer	6.88e-05	0.000332	CcSEcCtD
Ethacrynic acid—Nausea—Vincristine—hematologic cancer	6.88e-05	0.000332	CcSEcCtD
Ethacrynic acid—Asthenia—Etoposide—hematologic cancer	6.73e-05	0.000325	CcSEcCtD
Ethacrynic acid—Body temperature increased—Triamcinolone—hematologic cancer	6.73e-05	0.000325	CcSEcCtD
Ethacrynic acid—Decreased appetite—Dexamethasone—hematologic cancer	6.71e-05	0.000324	CcSEcCtD
Ethacrynic acid—Decreased appetite—Betamethasone—hematologic cancer	6.71e-05	0.000324	CcSEcCtD
Ethacrynic acid—Nausea—Mitoxantrone—hematologic cancer	6.7e-05	0.000323	CcSEcCtD
Ethacrynic acid—Nausea—Irinotecan—hematologic cancer	6.7e-05	0.000323	CcSEcCtD
Ethacrynic acid—Fatigue—Dexamethasone—hematologic cancer	6.66e-05	0.000321	CcSEcCtD
Ethacrynic acid—Fatigue—Betamethasone—hematologic cancer	6.66e-05	0.000321	CcSEcCtD
Ethacrynic acid—Chills—Epirubicin—hematologic cancer	6.64e-05	0.000321	CcSEcCtD
Ethacrynic acid—Pain—Dexamethasone—hematologic cancer	6.6e-05	0.000319	CcSEcCtD
Ethacrynic acid—Pain—Betamethasone—hematologic cancer	6.6e-05	0.000319	CcSEcCtD
Ethacrynic acid—Nausea—Gemcitabine—hematologic cancer	6.53e-05	0.000315	CcSEcCtD
Ethacrynic acid—Vomiting—Cisplatin—hematologic cancer	6.51e-05	0.000314	CcSEcCtD
Ethacrynic acid—Vision blurred—Methotrexate—hematologic cancer	6.49e-05	0.000313	CcSEcCtD
Ethacrynic acid—Rash—Cisplatin—hematologic cancer	6.46e-05	0.000312	CcSEcCtD
Ethacrynic acid—Dermatitis—Cisplatin—hematologic cancer	6.45e-05	0.000311	CcSEcCtD
Ethacrynic acid—Diarrhoea—Etoposide—hematologic cancer	6.42e-05	0.00031	CcSEcCtD
Ethacrynic acid—Anorexia—Prednisone—hematologic cancer	6.41e-05	0.000309	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Methotrexate—hematologic cancer	6.39e-05	0.000308	CcSEcCtD
Ethacrynic acid—Tinnitus—Doxorubicin—hematologic cancer	6.39e-05	0.000308	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Betamethasone—hematologic cancer	6.36e-05	0.000307	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Dexamethasone—hematologic cancer	6.36e-05	0.000307	CcSEcCtD
Ethacrynic acid—Malaise—Methotrexate—hematologic cancer	6.21e-05	0.0003	CcSEcCtD
Ethacrynic acid—Vertigo—Methotrexate—hematologic cancer	6.19e-05	0.000299	CcSEcCtD
Ethacrynic acid—Chills—Doxorubicin—hematologic cancer	6.15e-05	0.000297	CcSEcCtD
Ethacrynic acid—Asthenia—Triamcinolone—hematologic cancer	6.11e-05	0.000295	CcSEcCtD
Ethacrynic acid—Body temperature increased—Dexamethasone—hematologic cancer	6.1e-05	0.000295	CcSEcCtD
Ethacrynic acid—Body temperature increased—Betamethasone—hematologic cancer	6.1e-05	0.000295	CcSEcCtD
Ethacrynic acid—Nausea—Cisplatin—hematologic cancer	6.08e-05	0.000294	CcSEcCtD
Ethacrynic acid—Vision blurred—Epirubicin—hematologic cancer	6.07e-05	0.000293	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Epirubicin—hematologic cancer	5.98e-05	0.000289	CcSEcCtD
Ethacrynic acid—Convulsion—Methotrexate—hematologic cancer	5.97e-05	0.000288	CcSEcCtD
Ethacrynic acid—Vomiting—Etoposide—hematologic cancer	5.96e-05	0.000288	CcSEcCtD
Ethacrynic acid—Rash—Etoposide—hematologic cancer	5.92e-05	0.000285	CcSEcCtD
Ethacrynic acid—Dermatitis—Etoposide—hematologic cancer	5.91e-05	0.000285	CcSEcCtD
Ethacrynic acid—Headache—Etoposide—hematologic cancer	5.88e-05	0.000284	CcSEcCtD
Ethacrynic acid—Decreased appetite—Prednisone—hematologic cancer	5.85e-05	0.000282	CcSEcCtD
Ethacrynic acid—Rash—Prednisolone—hematologic cancer	5.83e-05	0.000282	CcSEcCtD
Ethacrynic acid—Dermatitis—Prednisolone—hematologic cancer	5.83e-05	0.000281	CcSEcCtD
Ethacrynic acid—Malaise—Epirubicin—hematologic cancer	5.81e-05	0.00028	CcSEcCtD
Ethacrynic acid—Fatigue—Prednisone—hematologic cancer	5.8e-05	0.00028	CcSEcCtD
Ethacrynic acid—Headache—Prednisolone—hematologic cancer	5.8e-05	0.00028	CcSEcCtD
Ethacrynic acid—Discomfort—Methotrexate—hematologic cancer	5.79e-05	0.00028	CcSEcCtD
Ethacrynic acid—Vertigo—Epirubicin—hematologic cancer	5.79e-05	0.000279	CcSEcCtD
Ethacrynic acid—Confusional state—Methotrexate—hematologic cancer	5.67e-05	0.000273	CcSEcCtD
Ethacrynic acid—Vision blurred—Doxorubicin—hematologic cancer	5.62e-05	0.000271	CcSEcCtD
Ethacrynic acid—Convulsion—Epirubicin—hematologic cancer	5.58e-05	0.000269	CcSEcCtD
Ethacrynic acid—Nausea—Etoposide—hematologic cancer	5.57e-05	0.000269	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Prednisone—hematologic cancer	5.54e-05	0.000267	CcSEcCtD
Ethacrynic acid—Asthenia—Betamethasone—hematologic cancer	5.54e-05	0.000267	CcSEcCtD
Ethacrynic acid—Asthenia—Dexamethasone—hematologic cancer	5.54e-05	0.000267	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Doxorubicin—hematologic cancer	5.53e-05	0.000267	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Methotrexate—hematologic cancer	5.5e-05	0.000266	CcSEcCtD
Ethacrynic acid—Nausea—Prednisolone—hematologic cancer	5.5e-05	0.000265	CcSEcCtD
Ethacrynic acid—Anxiety—Epirubicin—hematologic cancer	5.47e-05	0.000264	CcSEcCtD
Ethacrynic acid—Discomfort—Epirubicin—hematologic cancer	5.42e-05	0.000262	CcSEcCtD
Ethacrynic acid—Vomiting—Triamcinolone—hematologic cancer	5.41e-05	0.000261	CcSEcCtD
Ethacrynic acid—Malaise—Doxorubicin—hematologic cancer	5.38e-05	0.000259	CcSEcCtD
Ethacrynic acid—Rash—Triamcinolone—hematologic cancer	5.37e-05	0.000259	CcSEcCtD
Ethacrynic acid—Dermatitis—Triamcinolone—hematologic cancer	5.36e-05	0.000259	CcSEcCtD
Ethacrynic acid—Vertigo—Doxorubicin—hematologic cancer	5.36e-05	0.000259	CcSEcCtD
Ethacrynic acid—Anorexia—Methotrexate—hematologic cancer	5.36e-05	0.000259	CcSEcCtD
Ethacrynic acid—Headache—Triamcinolone—hematologic cancer	5.33e-05	0.000257	CcSEcCtD
Ethacrynic acid—Body temperature increased—Prednisone—hematologic cancer	5.32e-05	0.000257	CcSEcCtD
Ethacrynic acid—Confusional state—Epirubicin—hematologic cancer	5.3e-05	0.000256	CcSEcCtD
Ethacrynic acid—Diarrhoea—Betamethasone—hematologic cancer	5.28e-05	0.000255	CcSEcCtD
Ethacrynic acid—Diarrhoea—Dexamethasone—hematologic cancer	5.28e-05	0.000255	CcSEcCtD
Ethacrynic acid—Convulsion—Doxorubicin—hematologic cancer	5.17e-05	0.000249	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Epirubicin—hematologic cancer	5.15e-05	0.000248	CcSEcCtD
Ethacrynic acid—Anxiety—Doxorubicin—hematologic cancer	5.06e-05	0.000244	CcSEcCtD
Ethacrynic acid—Nausea—Triamcinolone—hematologic cancer	5.05e-05	0.000244	CcSEcCtD
Ethacrynic acid—Discomfort—Doxorubicin—hematologic cancer	5.01e-05	0.000242	CcSEcCtD
Ethacrynic acid—Anorexia—Epirubicin—hematologic cancer	5.01e-05	0.000242	CcSEcCtD
Ethacrynic acid—Vomiting—Betamethasone—hematologic cancer	4.91e-05	0.000237	CcSEcCtD
Ethacrynic acid—Vomiting—Dexamethasone—hematologic cancer	4.91e-05	0.000237	CcSEcCtD
Ethacrynic acid—Confusional state—Doxorubicin—hematologic cancer	4.91e-05	0.000237	CcSEcCtD
Ethacrynic acid—Decreased appetite—Methotrexate—hematologic cancer	4.88e-05	0.000236	CcSEcCtD
Ethacrynic acid—Rash—Dexamethasone—hematologic cancer	4.87e-05	0.000235	CcSEcCtD
Ethacrynic acid—Rash—Betamethasone—hematologic cancer	4.87e-05	0.000235	CcSEcCtD
Ethacrynic acid—Dermatitis—Betamethasone—hematologic cancer	4.86e-05	0.000235	CcSEcCtD
Ethacrynic acid—Dermatitis—Dexamethasone—hematologic cancer	4.86e-05	0.000235	CcSEcCtD
Ethacrynic acid—Fatigue—Methotrexate—hematologic cancer	4.84e-05	0.000234	CcSEcCtD
Ethacrynic acid—Headache—Dexamethasone—hematologic cancer	4.84e-05	0.000233	CcSEcCtD
Ethacrynic acid—Headache—Betamethasone—hematologic cancer	4.84e-05	0.000233	CcSEcCtD
Ethacrynic acid—Asthenia—Prednisone—hematologic cancer	4.82e-05	0.000233	CcSEcCtD
Ethacrynic acid—Pain—Methotrexate—hematologic cancer	4.81e-05	0.000232	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Doxorubicin—hematologic cancer	4.76e-05	0.00023	CcSEcCtD
Ethacrynic acid—Anorexia—Doxorubicin—hematologic cancer	4.64e-05	0.000224	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Methotrexate—hematologic cancer	4.63e-05	0.000223	CcSEcCtD
Ethacrynic acid—Diarrhoea—Prednisone—hematologic cancer	4.6e-05	0.000222	CcSEcCtD
Ethacrynic acid—Nausea—Betamethasone—hematologic cancer	4.59e-05	0.000221	CcSEcCtD
Ethacrynic acid—Nausea—Dexamethasone—hematologic cancer	4.59e-05	0.000221	CcSEcCtD
Ethacrynic acid—Decreased appetite—Epirubicin—hematologic cancer	4.57e-05	0.000221	CcSEcCtD
Ethacrynic acid—Fatigue—Epirubicin—hematologic cancer	4.53e-05	0.000219	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—NCOA3—hematologic cancer	4.52e-05	0.000641	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	4.51e-05	0.000639	CbGpPWpGaD
Ethacrynic acid—Pain—Epirubicin—hematologic cancer	4.5e-05	0.000217	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—NUP214—hematologic cancer	4.49e-05	0.000637	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—ICAM1—hematologic cancer	4.47e-05	0.000635	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Methotrexate—hematologic cancer	4.44e-05	0.000214	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.41e-05	0.000625	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTR—hematologic cancer	4.4e-05	0.000624	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ABCG2—hematologic cancer	4.4e-05	0.000624	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Epirubicin—hematologic cancer	4.33e-05	0.000209	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.31e-05	0.000612	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ENO2—hematologic cancer	4.31e-05	0.000612	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IFNG—hematologic cancer	4.29e-05	0.000608	CbGpPWpGaD
Ethacrynic acid—Vomiting—Prednisone—hematologic cancer	4.28e-05	0.000206	CcSEcCtD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—NUP98—hematologic cancer	4.25e-05	0.000603	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SPARC—hematologic cancer	4.25e-05	0.000603	CbGpPWpGaD
Ethacrynic acid—Rash—Prednisone—hematologic cancer	4.24e-05	0.000205	CcSEcCtD
Ethacrynic acid—Dermatitis—Prednisone—hematologic cancer	4.24e-05	0.000204	CcSEcCtD
Ethacrynic acid—Decreased appetite—Doxorubicin—hematologic cancer	4.23e-05	0.000204	CcSEcCtD
Ethacrynic acid—ALB—Hemostasis—ATP1B1—hematologic cancer	4.22e-05	0.000599	CbGpPWpGaD
Ethacrynic acid—Headache—Prednisone—hematologic cancer	4.21e-05	0.000203	CcSEcCtD
Ethacrynic acid—Fatigue—Doxorubicin—hematologic cancer	4.2e-05	0.000202	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTT1—hematologic cancer	4.18e-05	0.000593	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—S100A10—hematologic cancer	4.18e-05	0.000593	CbGpPWpGaD
Ethacrynic acid—Pain—Doxorubicin—hematologic cancer	4.16e-05	0.000201	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.16e-05	0.00059	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Epirubicin—hematologic cancer	4.16e-05	0.000201	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—LCK—hematologic cancer	4.12e-05	0.000584	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—NUP214—hematologic cancer	4.1e-05	0.000582	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SDC1—hematologic cancer	4.09e-05	0.00058	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	4.09e-05	0.00058	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.04e-05	0.000573	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.04e-05	0.000573	CbGpPWpGaD
Ethacrynic acid—Asthenia—Methotrexate—hematologic cancer	4.03e-05	0.000195	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Doxorubicin—hematologic cancer	4.01e-05	0.000194	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.01e-05	0.000568	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—CCL2—hematologic cancer	4e-05	0.000568	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GATA1—hematologic cancer	4e-05	0.000567	CbGpPWpGaD
Ethacrynic acid—Nausea—Prednisone—hematologic cancer	3.99e-05	0.000193	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—HSPA5—hematologic cancer	3.98e-05	0.000564	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.93e-05	0.000557	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PRKCZ—hematologic cancer	3.92e-05	0.000557	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.92e-05	0.000555	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.89e-05	0.000551	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Doxorubicin—hematologic cancer	3.85e-05	0.000186	CcSEcCtD
Ethacrynic acid—Diarrhoea—Methotrexate—hematologic cancer	3.84e-05	0.000186	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—IL1B—hematologic cancer	3.82e-05	0.000542	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL2—hematologic cancer	3.81e-05	0.00054	CbGpPWpGaD
Ethacrynic acid—Asthenia—Epirubicin—hematologic cancer	3.77e-05	0.000182	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.67e-05	0.00052	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ANXA2—hematologic cancer	3.66e-05	0.000519	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.65e-05	0.000518	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Epirubicin—hematologic cancer	3.6e-05	0.000174	CcSEcCtD
Ethacrynic acid—Vomiting—Methotrexate—hematologic cancer	3.57e-05	0.000172	CcSEcCtD
Ethacrynic acid—Rash—Methotrexate—hematologic cancer	3.54e-05	0.000171	CcSEcCtD
Ethacrynic acid—Dermatitis—Methotrexate—hematologic cancer	3.54e-05	0.000171	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL3—hematologic cancer	3.53e-05	0.0005	CbGpPWpGaD
Ethacrynic acid—Headache—Methotrexate—hematologic cancer	3.52e-05	0.00017	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.5e-05	0.000496	CbGpPWpGaD
Ethacrynic acid—Asthenia—Doxorubicin—hematologic cancer	3.49e-05	0.000168	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—NQO1—hematologic cancer	3.48e-05	0.000493	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CD44—hematologic cancer	3.48e-05	0.000493	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PTPN1—hematologic cancer	3.47e-05	0.000492	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.46e-05	0.000491	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RASGRP1—hematologic cancer	3.41e-05	0.000484	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—TNF—hematologic cancer	3.41e-05	0.000484	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IFNG—hematologic cancer	3.4e-05	0.000483	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GNA13—hematologic cancer	3.4e-05	0.000482	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SYK—hematologic cancer	3.4e-05	0.000482	CbGpPWpGaD
Ethacrynic acid—Vomiting—Epirubicin—hematologic cancer	3.34e-05	0.000161	CcSEcCtD
Ethacrynic acid—Nausea—Methotrexate—hematologic cancer	3.34e-05	0.000161	CcSEcCtD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	3.33e-05	0.000472	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Doxorubicin—hematologic cancer	3.33e-05	0.000161	CcSEcCtD
Ethacrynic acid—Rash—Epirubicin—hematologic cancer	3.32e-05	0.00016	CcSEcCtD
Ethacrynic acid—Dermatitis—Epirubicin—hematologic cancer	3.31e-05	0.00016	CcSEcCtD
Ethacrynic acid—Headache—Epirubicin—hematologic cancer	3.29e-05	0.000159	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CYCS—hematologic cancer	3.29e-05	0.000466	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HSP90AA1—hematologic cancer	3.27e-05	0.000464	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITGAX—hematologic cancer	3.25e-05	0.00046	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—JAK3—hematologic cancer	3.25e-05	0.00046	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CD9—hematologic cancer	3.2e-05	0.000454	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—F3—hematologic cancer	3.2e-05	0.000454	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.17e-05	0.000449	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.17e-05	0.000449	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.17e-05	0.000449	CbGpPWpGaD
Ethacrynic acid—Nausea—Epirubicin—hematologic cancer	3.12e-05	0.000151	CcSEcCtD
Ethacrynic acid—ALB—Hemostasis—SELL—hematologic cancer	3.11e-05	0.000441	CbGpPWpGaD
Ethacrynic acid—Vomiting—Doxorubicin—hematologic cancer	3.09e-05	0.000149	CcSEcCtD
Ethacrynic acid—Rash—Doxorubicin—hematologic cancer	3.07e-05	0.000148	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	3.07e-05	0.000435	CbGpPWpGaD
Ethacrynic acid—Dermatitis—Doxorubicin—hematologic cancer	3.07e-05	0.000148	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	3.06e-05	0.000434	CbGpPWpGaD
Ethacrynic acid—Headache—Doxorubicin—hematologic cancer	3.05e-05	0.000147	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	3.04e-05	0.000431	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL3RA—hematologic cancer	3.03e-05	0.00043	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	3.02e-05	0.000428	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.94e-05	0.000417	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.91e-05	0.000413	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—hematologic cancer	2.9e-05	0.000411	CbGpPWpGaD
Ethacrynic acid—Nausea—Doxorubicin—hematologic cancer	2.89e-05	0.000139	CcSEcCtD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.86e-05	0.000405	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.85e-05	0.000404	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GMPS—hematologic cancer	2.82e-05	0.000401	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PHYH—hematologic cancer	2.82e-05	0.000401	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—FTCD—hematologic cancer	2.82e-05	0.000401	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.8e-05	0.000397	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—hematologic cancer	2.77e-05	0.000394	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TNF—hematologic cancer	2.77e-05	0.000393	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—H3F3B—hematologic cancer	2.77e-05	0.000393	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—FGR—hematologic cancer	2.77e-05	0.000393	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	2.77e-05	0.000393	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	2.75e-05	0.00039	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ABCB1—hematologic cancer	2.74e-05	0.000389	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	2.74e-05	0.000389	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITGAL—hematologic cancer	2.67e-05	0.000379	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MYB—hematologic cancer	2.67e-05	0.000379	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NCOR1—hematologic cancer	2.66e-05	0.000378	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—hematologic cancer	2.66e-05	0.000378	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.66e-05	0.000378	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	2.64e-05	0.000375	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	2.64e-05	0.000375	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	2.64e-05	0.000375	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.63e-05	0.000373	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SMPD3—hematologic cancer	2.58e-05	0.000366	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.58e-05	0.000365	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—TGFB1—hematologic cancer	2.55e-05	0.000361	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RAC2—hematologic cancer	2.54e-05	0.00036	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.5e-05	0.000355	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	2.47e-05	0.00035	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.45e-05	0.000348	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—hematologic cancer	2.45e-05	0.000347	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	2.43e-05	0.000344	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.41e-05	0.000342	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	2.38e-05	0.000338	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTHFR—hematologic cancer	2.35e-05	0.000334	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.35e-05	0.000333	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SH2B3—hematologic cancer	2.3e-05	0.000326	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.29e-05	0.000325	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—DCK—hematologic cancer	2.26e-05	0.00032	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—B3GAT1—hematologic cancer	2.26e-05	0.00032	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ASNS—hematologic cancer	2.26e-05	0.00032	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL6—hematologic cancer	2.24e-05	0.000317	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	2.22e-05	0.000315	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.21e-05	0.000313	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	2.2e-05	0.000313	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SPARC—hematologic cancer	2.19e-05	0.000311	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.16e-05	0.000307	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	2.15e-05	0.000305	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HDC—hematologic cancer	2.14e-05	0.000304	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—LCK—hematologic cancer	2.12e-05	0.000301	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.1e-05	0.000298	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.08e-05	0.000295	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—H3F3A—hematologic cancer	2.08e-05	0.000295	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GATA3—hematologic cancer	2.06e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	2.06e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HSPA5—hematologic cancer	2.05e-05	0.000291	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.04e-05	0.000289	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PRKCZ—hematologic cancer	2.02e-05	0.000287	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2e-05	0.000283	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CG—hematologic cancer	1.98e-05	0.000281	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CDA—hematologic cancer	1.96e-05	0.000278	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HDAC2—hematologic cancer	1.88e-05	0.000267	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PC—hematologic cancer	1.88e-05	0.000267	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CD44—hematologic cancer	1.86e-05	0.000264	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITGA4—hematologic cancer	1.86e-05	0.000264	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CREBBP—hematologic cancer	1.83e-05	0.00026	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GBA—hematologic cancer	1.82e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC35B2—hematologic cancer	1.82e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.82e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL3—hematologic cancer	1.82e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.81e-05	0.000257	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IFNA1—hematologic cancer	1.81e-05	0.000256	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PTPN1—hematologic cancer	1.79e-05	0.000253	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.78e-05	0.000252	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RASGRP1—hematologic cancer	1.76e-05	0.000249	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SYK—hematologic cancer	1.75e-05	0.000249	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CD—hematologic cancer	1.74e-05	0.000247	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALB—hematologic cancer	1.72e-05	0.000243	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.71e-05	0.000242	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IFNA2—hematologic cancer	1.68e-05	0.000238	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTAP—hematologic cancer	1.66e-05	0.000236	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.66e-05	0.000235	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3R1—hematologic cancer	1.64e-05	0.000233	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.64e-05	0.000232	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GRB2—hematologic cancer	1.58e-05	0.000224	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PDGFA—hematologic cancer	1.58e-05	0.000224	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.58e-05	0.000224	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.53e-05	0.000217	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.53e-05	0.000217	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ABL1—hematologic cancer	1.52e-05	0.000216	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CB—hematologic cancer	1.52e-05	0.000215	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—FHL2—hematologic cancer	1.48e-05	0.00021	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AGRN—hematologic cancer	1.45e-05	0.000206	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.45e-05	0.000205	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HGF—hematologic cancer	1.43e-05	0.000203	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CSF2—hematologic cancer	1.41e-05	0.0002	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMMR—hematologic cancer	1.38e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—IDH2—hematologic cancer	1.38e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—JAK1—hematologic cancer	1.36e-05	0.000193	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PRKCG—hematologic cancer	1.36e-05	0.000193	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTEN—hematologic cancer	1.31e-05	0.000186	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.3e-05	0.000184	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ARNTL—hematologic cancer	1.3e-05	0.000184	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.27e-05	0.000181	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2RA—hematologic cancer	1.27e-05	0.000181	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.26e-05	0.000179	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ACP5—hematologic cancer	1.26e-05	0.000179	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CA9—hematologic cancer	1.26e-05	0.000179	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—EP300—hematologic cancer	1.25e-05	0.000177	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOR2—hematologic cancer	1.24e-05	0.000177	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.23e-05	0.000175	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PDGFB—hematologic cancer	1.23e-05	0.000174	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CDK2—hematologic cancer	1.19e-05	0.000169	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—IDH1—hematologic cancer	1.19e-05	0.000168	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCC3—hematologic cancer	1.17e-05	0.000166	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTO1—hematologic cancer	1.17e-05	0.000166	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TXN—hematologic cancer	1.17e-05	0.000166	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	1.16e-05	0.000165	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SPHK1—hematologic cancer	1.15e-05	0.000163	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MAPK14—hematologic cancer	1.14e-05	0.000162	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	1.13e-05	0.00016	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—FN1—hematologic cancer	1.11e-05	0.000157	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UGT1A1—hematologic cancer	1.1e-05	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC22A1—hematologic cancer	1.07e-05	0.000152	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CRABP1—hematologic cancer	1.07e-05	0.000152	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CG—hematologic cancer	1.06e-05	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALOX5—hematologic cancer	1.05e-05	0.000148	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PTPN11—hematologic cancer	1.04e-05	0.000148	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NUP98—hematologic cancer	1.01e-05	0.000144	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CREBBP—hematologic cancer	9.83e-06	0.000139	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADCY7—hematologic cancer	9.83e-06	0.000139	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA3—hematologic cancer	9.83e-06	0.000139	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NUP214—hematologic cancer	9.76e-06	0.000138	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.66e-06	0.000137	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	9.61e-06	0.000136	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTR—hematologic cancer	9.56e-06	0.000136	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCG2—hematologic cancer	9.56e-06	0.000136	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ENO2—hematologic cancer	9.37e-06	0.000133	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CD—hematologic cancer	9.32e-06	0.000132	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CA—hematologic cancer	9.24e-06	0.000131	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—hematologic cancer	9.09e-06	0.000129	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.95e-06	0.000127	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SDC1—hematologic cancer	8.89e-06	0.000126	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3R1—hematologic cancer	8.81e-06	0.000125	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—JAK2—hematologic cancer	8.56e-06	0.000121	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.51e-06	0.000121	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.49e-06	0.00012	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CB—hematologic cancer	8.13e-06	0.000115	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.02e-06	0.000114	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	7.85e-06	0.000111	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CD44—hematologic cancer	7.56e-06	0.000107	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NQO1—hematologic cancer	7.56e-06	0.000107	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AKT1—hematologic cancer	7.55e-06	0.000107	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2—hematologic cancer	7.46e-06	0.000106	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.4e-06	0.000105	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYCS—hematologic cancer	7.15e-06	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSP90AA1—hematologic cancer	7.1e-06	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EP300—hematologic cancer	6.7e-06	9.5e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SRC—hematologic cancer	6.51e-06	9.24e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.39e-06	9.07e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—hematologic cancer	6.34e-06	9e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—hematologic cancer	6.3e-06	8.94e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NRAS—hematologic cancer	6.27e-06	8.89e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.1e-06	8.65e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MAPK3—hematologic cancer	6e-06	8.51e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCB1—hematologic cancer	5.97e-06	8.46e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB1—hematologic cancer	5.82e-06	8.26e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOR1—hematologic cancer	5.79e-06	8.21e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—hematologic cancer	5.79e-06	8.21e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KRAS—hematologic cancer	5.39e-06	7.65e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTHFR—hematologic cancer	5.12e-06	7.26e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CA—hematologic cancer	4.95e-06	7.03e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—hematologic cancer	4.79e-06	6.8e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HRAS—hematologic cancer	4.58e-06	6.5e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.51e-06	6.4e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CG—hematologic cancer	4.3e-06	6.1e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT1—hematologic cancer	4.05e-06	5.74e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CREBBP—hematologic cancer	3.99e-06	5.66e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CD—hematologic cancer	3.78e-06	5.36e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3R1—hematologic cancer	3.57e-06	5.06e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CB—hematologic cancer	3.3e-06	4.67e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTEN—hematologic cancer	2.85e-06	4.04e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—EP300—hematologic cancer	2.72e-06	3.85e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CA—hematologic cancer	2.01e-06	2.85e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKT1—hematologic cancer	1.64e-06	2.33e-05	CbGpPWpGaD
